Enanta Pharmaceuticals, Inc.ENTANASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank71
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
29.86%
↑ 218% vs avg
Percentile
P71
Within normal range
Streak
5 yr
Consecutive growthAccelerating
Average
-25.40%
Historical baseline
PeriodValue
202529.86%
202411.31%
2023-10.79%
2022-13.02%
2021-163.15%
2020-213.34%
2019-58.41%
2018258.85%
2017-20.19%
2016-75.16%